Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rs3802278 in 3'-UTR of SULF1 associated with platinum resistance and survival in Chinese epithelial ovarian cancer patients.

Journal of chemotherapy (Florence, Italy) - 1 Dec 2021

Zeng Feiyue, Liu Yujie, Ouyang Qianying, Sun Zeen, Zhang Keqiang, Li Xi, Liu Yingzi

Abstract excerpt

Ovarian cancer is the leading cause of death from gynecologic cancers, but platinum resistance remains a major obstacle in the chemotherapy of ovarian cancer. This study aims to examine the role of polymorphisms in sulfatase 1 (SULF1) in platinum resistance and survival in advanced epithelial ovarian cancer (EOC) patients. We genotyped 12 SNPs of SULF1 in 195 EOC patients treated with platinum using MassARRAY...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Carcinoma, Ovarian Epithelial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Platinum Compounds

Share to Sulfotransferases

Share to Survival Analysis

Source

Identifiers

PMID: 34029511
DOI: 10.1080/1120009X.2021.1913702

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rs3802278 in 3'-UTR of SULF1 associated with platinum resistance and survival in Chinese epithelial ovarian cancer patients.PMID 34029511Read ↗

Incorporating SULF1 polymorphisms in a pretreatment CT-based radiomic model for predicting platinum resistance in ovarian cancer treatment.Semantic proximity Read ↗

Potentially functional variants in nucleotide excision repair pathway genes predict platinum treatment response of Chinese ovarian cancer patients.Semantic proximity Read ↗

Construction and Validation of a Platinum Sensitivity Predictive Model With Multiple Genomic Variations for Epithelial Ovarian CancerSemantic proximity Read ↗

A risk model of gene signatures for predicting platinum response and survival in ovarian cancerSemantic proximity Read ↗

Identification of platinum-resistance related small GTPase binding signatures to predict the prognosis of ovarian cancer by machine learning and integrated bioinformatic analysesSemantic proximity Read ↗

The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancerSemantic proximity Read ↗

INSR gene polymorphisms correlate with sensitivity to platinum-based chemotherapy and prognosis in patients with epithelial ovarian cancer.Semantic proximity Read ↗

Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer.Semantic proximity Read ↗

hMSH2 Coordinated with the Expression of E2F1 Promotes Platinum Response in Epithelial Ovarian CancerSemantic proximity Read ↗

Microarray‐based identification of genes associated with prognosis and drug resistance in ovarian cancerSemantic proximity Read ↗

Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancerSemantic proximity Read ↗

Promoter Methylation of the MGRN1 Gene Response to Chemotherapy of Epithelial Ovarian Cancer PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.